2,454 followers
A phase 1, open-label, single-dose study of the pharmacokinetics of zanubrutinib in subjects with varying degrees of hepatic impairment. #lymphoma #lymsm https://t.co/1bdTLualcN
A phase 1, open-label, single-dose study of the pharmacokinetics of zanubrutinib in subjects with varying degrees of hepatic impairment
Overview of attention for article published in Leukemia & Lymphoma, February 2020